These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27351762)

  • 41. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes.
    Chen W; Liu B; Chen J; Liu G; Liu X
    Acta Radiol; 2017 May; 58(5):573-580. PubMed ID: 27565629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T2 magnetic resonance imaging.
    Do MA; Yoon GJ; Yeum JH; Han M; Chang Y; Choi JH
    Colloids Surf B Biointerfaces; 2014 Oct; 122():752-759. PubMed ID: 25194592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
    Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
    Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid.
    Beyk J; Tavakoli H
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2199-2209. PubMed ID: 31309302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imaging.
    Yang HM; Park CW; Woo MA; Kim MI; Jo YM; Park HG; Kim JD
    Biomacromolecules; 2010 Nov; 11(11):2866-72. PubMed ID: 20932000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection.
    Qiao Y; Gumin J; MacLellan CJ; Gao F; Bouchard R; Lang FF; Stafford RJ; Melancon MP
    Nanotechnology; 2018 Apr; 29(16):165101. PubMed ID: 29438105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.
    Patel D; Bassi R; Hooper A; Prewett M; Hicklin DJ; Kang X
    Int J Oncol; 2009 Jan; 34(1):25-32. PubMed ID: 19082474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trastuzumab-conjugated liposome-coated fluorescent magnetic nanoparticles to target breast cancer.
    Jang M; Yoon YI; Kwon YS; Yoon TJ; Lee HJ; Hwang SI; Yun BL; Kim SM
    Korean J Radiol; 2014; 15(4):411-22. PubMed ID: 25053899
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
    Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
    Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Cell-Penetrating Peptide Improves Anti-HER2 Single-Chain Variable Fragment Internalization and Antitumor Activity against HER2-Positive Breast Cancer In Vitro and In Vivo.
    Li J; Zhou Y; Su Z; Li X; Zhang L; Li S
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
    Dan M; Cochran DB; Yokel RA; Dziubla TD
    PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CXCR4-targeted and MMP-responsive iron oxide nanoparticles for enhanced magnetic resonance imaging.
    Gallo J; Kamaly N; Lavdas I; Stevens E; Nguyen QD; Wylezinska-Arridge M; Aboagye EO; Long NJ
    Angew Chem Int Ed Engl; 2014 Sep; 53(36):9550-4. PubMed ID: 25045009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-HER2 scFv Expression in Escherichia coli SHuffle
    Ahmadzadeh M; Farshdari F; Nematollahi L; Behdani M; Mohit E
    Mol Biotechnol; 2020 Jan; 62(1):18-30. PubMed ID: 31691197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
    Bonvin D; Bastiaansen JAM; Stuber M; Hofmann H; Mionić Ebersold M
    Dalton Trans; 2017 Sep; 46(37):12692-12704. PubMed ID: 28914298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
    Ahmed N; Ahmad NM; Fessi H; Elaissari A
    Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
    Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
    Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts.
    Balandin TG; Edelweiss E; Andronova NV; Treshalina EM; Sapozhnikov AM; Deyev SM
    Invest New Drugs; 2011 Feb; 29(1):22-32. PubMed ID: 19789841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
    Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
    Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.